Amwell raised $742 million as upsized IPO prices above expected range – MarketWatch

Amwell raised $742 million as upsized IPO prices above expected range – MarketWatch thumbnail image

Written by Tomi Kilgore

American Well Corp. AMWL, -0.09%, known as Amwell, said late Wednesday that its upsized initial public offering priced at $18 a share, above the expected range of between $14 and $16 a share, as the Boston-based telemedicine …

By Maria Ordonez
Maria Ordonez Profile Picture
Read more »

Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Adults with Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer – Blueprint Medicines

blueprint-medicines-event

Sourced from Blueprint Medicines News Release

— GAVRETO, the only once-daily RET-targeted therapy, demonstrated durable efficacy, with complete responses in a subset of patients —
— Blueprint Medicines and Genentech will co-commercialize GAVRETO in the U.S. —
— FDA approval …

By Jessica Yap-Chung
Jessica Yap-Chung Profile Picture
Read more »

20-second coronavirus screening test piloted at U.K.’s Heathrow airport – FierceBiotech

Screen Shot 2020-09-11 at 10.02.27 AM

Written by Conor Hale

Two British companies are preparing to launch a simple COVID-19 saliva screening test that aims to provide an accurate result within 20 seconds—following its first uses at London’s Heathrow airport, one of the busiest in the …

By Jessica Yap-Chung
Jessica Yap-Chung Profile Picture
Read more »

Thermo Fisher builds $40M coronavirus test tube manufacturing facility in 6 weeks – Fierce Biotech

thermo fisher

Written by Conor Hale

To help meet the relentless demand for COVID-19 diagnostics, Thermo Fisher Scientific has stood up a new, $40 million manufacturing facility in six weeks.

The 120,000-square-foot plant at its Lenexa, Kansas site will be dedicated to …

By Bingyi Zeng
Bingyi Zeng Profile Picture
Read more »

FDA approves Medtronic MiniMed 770G insulin pump for young children – Mass Device

fda approves

Written by Nancy Crotti

The FDA has approved the Medtronic (NYSE:MDTMiniMed 770G  hybrid closed loop-diabetes management system for Type 1 diabetes patients aged 2 to 6 years.

The MiniMed 770G is the first-of-its-kind system that can automatically adjust …

By Bingyi Zeng
Bingyi Zeng Profile Picture
Read more »